The NF-κB and TGF-β pathways have been described to influence the prognosis in several types of STS, including malignant fibrous histiocytoma, Ewing sarcoma, osteosarcoma and rhabdomyosarcoma [17]–[21]. The gene discussed is NFKB1; the disease is telomere syndrome.